OpenURL Connection Search

Select item for more details and to access through your institution.

Increased incidence of obstetric complications in women carrying mitochondrial DNA mutations: a retrospective cohort study in a single tertiary centre.
Published in:
2019
By:
- Kuleva, M;
- Ben Miled, S;
- Steffann, J;
- Bonnefont, JP;
- Rondeau, S;
- Ville, Y;
- Munnich, A;
- Salomon, LJ;
- Bonnefont, J P;
- Salomon, L J
Publication type:
journal article
EP17.13: Increased incidence of obstetric complications in women carrying mitochondrial DNA mutations.
Published in:
Ultrasound in Obstetrics & Gynecology, 2017, v. 50, p. 341, doi. 10.1002/uog.18606
By:
- Kuleva, M.;
- Ben Miled, S.;
- Steffann, J.;
- Bonnefont, J.;
- Rondeau, S.;
- Ville, Y.;
- Munnich, A.;
- Salomon, L.J.
Publication type:
Article
Erratum: Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.
Published in:
2017
By:
- Lemonnier, E;
- Villeneuve, N;
- Sonie, S;
- Serret, S;
- Rosier, A;
- Roue, M;
- Brosset, P;
- Viellard, M;
- Bernoux, D;
- Rondeau, S;
- Thummler, S;
- Ravel, D;
- Ben-Ari, Y
Publication type:
Correction Notice
ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels.
Published in:
British Journal of Cancer, 2015, v. 112, n. 6, p. 1059, doi. 10.1038/bjc.2015.60
By:
- Rondeau, S;
- Vacher, S;
- De Koning, L;
- Briaux, A;
- Schnitzler, A;
- Chemlali, W;
- Callens, C;
- Lidereau, R;
- Bièche, I
Publication type:
Article
Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10).
Published in:
Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0228-2
By:
- Hitz, F.;
- Kraus, M.;
- Pabst, T.;
- Hess, D.;
- Besse, L.;
- Silzle, T.;
- Novak, U.;
- Seipel, K.;
- Rondeau, S.;
- Stüdeli, S.;
- Vilei, S. Berardi;
- Samaras, P.;
- Mey, U.;
- Driessen, C.
Publication type:
Article
SAKK 36/13-IBRUTINIB AND BORTEZOMIB FOLLOWED BY IBRUTINIB MAINTENANCE IN PATIENTS WITH RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA: PHASE I REPORT OF A PHASE I/II TRIAL.
Published in:
Hematological Oncology, 2017, v. 35, p. 207, doi. 10.1002/hon.2438_71
By:
- Novak, U.;
- Fehr, M.;
- Zander, T.;
- Winterhalder, R.;
- Amram, M.;
- Stathis, A.;
- Rondeau, S.;
- Berardi, S.;
- Eckhardt, K.;
- Driessen, C.;
- Renner, C.
Publication type:
Article

Found: 6

Increased incidence of obstetric complications in women carrying mitochondrial DNA mutations: a retrospective cohort study in a single tertiary centre.

EP17.13: Increased incidence of obstetric complications in women carrying mitochondrial DNA mutations.

Erratum: Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.

ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels.

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10).

SAKK 36/13-IBRUTINIB AND BORTEZOMIB FOLLOWED BY IBRUTINIB MAINTENANCE IN PATIENTS WITH RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA: PHASE I REPORT OF A PHASE I/II TRIAL.